Eli Lilly and Company LLY announced a settlement agreement with Totality ... which has also filed lawsuits against pharmacies that claim their products contain its active ingredient, semaglutide.

US-based drugmaker Eli Lilly has entered into a settlement deal with a medi spa ... Novo Nordisk sued one compounding pharmacy and refiled a lawsuit against another after finding their products ...

To what extent will health clinics go to keep selling in-demand weight-loss drugs now that the FDA has outlawed cheaper ...

A Lilly statement said, "We will continue to take action to stop these illegal actors and urgently call on regulators and law ...

Eli Lilly is suing Strive Pharmacy and Empower Pharmacy for compounding tirzepatide, the active ingredient in Zepbound and Mounjaro.

Eli Lilly has filed a $500 million lawsuit against the Canadian government alleging its patent laws are inconsistent and that it unfairly shortened the patent life for some of Lilly's best-selling ...

The FDA has said it has agreed to reconsider its decision to prevent compounding pharmacies from producing and selling versions of Eli ... Novo Nordisk and Lilly both filing lawsuits seeking ...

(The Hill) – A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight ... tirzepatide. The lawsuit against the FDA was brought ...

The company has also responded to legal challenges, settling insulin pricing lawsuits for US$500 million. Combined with its robust non-cash earnings, these elements help illustrate Eli Lilly's ...

INDIANAPOLIS — Eli Lilly ... drugs being sold. Lilly claims Premier Weight Loss is selling altered versions of Lilly's weight loss drugs Zepbound and Mounjaro. In the lawsuit, Lilly alleges ...